tradingkey.logo
tradingkey.logo
Search

Stryker Corp

SYK
Add to Watchlist
314.520USD
-16.000-4.84%
Close 06/30, 16:00ETQuotes delayed by 15 min
120.30BMarket Cap
36.05P/E TTM

TradingKey Stock Score of Stryker Corp

Currency: USD Updated: 2026-06-29

Key Insights

Stryker Corp's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 6 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 387.27.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Stryker Corp's Score

Industry at a Glance

Industry Ranking
6 / 204
Overall Ranking
39 / 4570
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

29°C

Very Low
Very High
Negative

Stryker Corp Highlights

StrengthsRisks
Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 22.53% year-on-year.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 41.30%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 41.30%.
Undervalued
The company’s latest PE is 37.88, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 312.34M shares, decreasing 1.14% quarter-over-quarter.
Held by Jerome Dodson | PARNX
Star Investor Jerome Dodson | PARNX holds 2.19M shares of this stock.

Analyst Rating

Based on 31 analysts
Buy
Current Rating
387.267
Target Price
+17.17%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

FAQs

How does TradingKey generate the Stock Score of Stryker Corp?

The TradingKey Stock Score provides a comprehensive assessment of Stryker Corp based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Stryker Corp’s performance and outlook.

How do we generate the financial health score of Stryker Corp?

To generate the financial health score of Stryker Corp, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Stryker Corp's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Stryker Corp.

How do we generate the company valuation score of Stryker Corp?

To generate the company valuation score of Stryker Corp, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Stryker Corp’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Stryker Corp’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Stryker Corp.

How do we generate the earnings forecast score of Stryker Corp?

To calculate the earnings forecast score of Stryker Corp, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Stryker Corp’s future.

How do we generate the price momentum score of Stryker Corp?

When generating the price momentum score for Stryker Corp, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Stryker Corp’s prices. A higher score indicates a more stable short-term price trend for Stryker Corp.

How do we generate the institutional confidence score of Stryker Corp?

To generate the institutional confidence score of Stryker Corp, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Stryker Corp’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Stryker Corp.

How do we generate the risk management score of Stryker Corp?

To assess the risk management score of Stryker Corp, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Stryker Corp’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Stryker Corp.
KeyAI